Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Construction in Progress (2019 - 2020)

Historic Construction in Progress for Legend Biotech (LEGN) over the last 2 years, with Q4 2020 value amounting to $33.6 million.

  • Legend Biotech's Construction in Progress rose 108273.56% to $33.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $33.6 million, marking a year-over-year increase of 108273.56%. This contributed to the annual value of $33.6 million for FY2020, which is 108273.56% up from last year.
  • Per Legend Biotech's latest filing, its Construction in Progress stood at $33.6 million for Q4 2020, which was up 108273.56% from $2.8 million recorded in Q4 2019.
  • Legend Biotech's 5-year Construction in Progress high stood at $33.6 million for Q4 2020, and its period low was $2.8 million during Q4 2019.